Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,774
datasets available to search
ShareScore release 0.9.0
Dataset results
2,774 results for “Agent”
Figure 1 Aceria alhagi n in A new Aceria species (Acari:Trombidiformes: Eriophyoidea) from West Asia, a potential biological control agent for the invasive weed camelthorn, Alhagi maurorum Medik. (Leguminosae)
Figure 1 Aceria alhagi n.sp.: AD – Antero-dorsal mite; AL – Antero-lateral view of mite; CG – Coxigenital region of female; em – Empodium; GM – Genital region of male; IG – Internal female genitalia; L1 – Leg I of female; LO – Lateral opisthosoma; PM – Postero-lateral mite. Scale bar: 20μm for AD, AL,CG, GM, IG, LO, PM; 10μm for L1; 5μm for em.
Figure 2 SEM images ofAceria alhagi n in A new Aceria species (Acari:Trombidiformes: Eriophyoidea) from West Asia, a potential biological control agent for the invasive weed camelthorn, Alhagi maurorum Medik. (Leguminosae)
Figure 2 SEM images ofAceria alhagi n. sp.: A – prodorsal shield; B – tarsal empodia on legs I and II; C – ventral view of coxigenital area of female; D – ventral view of coxigenital area of male.
Graph Laplacians used in the article "Numerically Efficient $H_{\infty}$ Analysis of Cooperative Multi-Agent Systems"
<p>The repository contains four graph Laplacians written in the Matlab format. These matrices are used in the section "Numerical Examples" in the article "Numerically Efficient $H_{\infty}$ Analysis of Cooperative Multi-Agent Systems".</p>
Data set for article "Migrant Entrepreneurs as Agents of Development? Geopolitical Context and Transmobility Strategies of Colombian Migrants Returning from Venezuela"
<p>Data set for paper "Migrant Entrepreneurs as Agents of Development? Geopolitical Context and Transmobility Strategies of Colombian Migrants Returning from Venezuela"</p>
Risk of bias in assessed studies for LSR: Antiplatelet agents for the treatment of adults with COVID-19
<p>This is our RoB2 excel sheet, in which detailled information about our risk of bias rating can be found. This concerns the outcomes of studies included in our LSR Antiplatelet agents for the treatment of adults with COVID-19. The first version is published before publication of the review.</p>
Supplementary Material for "Recursive Small-Step Multi-Agent A* for Dec-POMDPs"
<p>This artefact accompanies the IJCAI 2023 paper with the same name.<br> Please refer to the README for more information.</p>
CausalOrca: An ORCA-based Diagnostic Dataset for Causally-aware Multi-agent Trajectory Prediction
<p>CausalOrca is a synthetic diagnostic dataset created through controlled simulations. It is designed to provide annotations of ground-truth causal effects and fine-grained agent categories for social interactions in multi-agent scenarios. The dataset is constructed using a modified RVO2 simulator and incorporates the ORCA optimization-based collision avoidance algorithm known for crowd simulation. With full control over scene configurations, the dataset enables the collection of motion behaviors in paired scenes before and after agent removal, generating a large set of counterfactual pairs with annotations of ground-truth causal effects. CausalOrca can serve as a valuable resource for studying and developing causally-aware neural representations of social interactions and trajectory prediction models. Please see the <a href="https://github.com/rebuttal-anonymous/causalorca">GitHub repository</a> for a more detailed description of the dataset, including dataset statistics and documentation on how to use, visualize, and generate the data.</p>
Agent level Synthetic Freight Population
<p>Each row represents a unique tour with the following properties: Flow, NAICS number, Light/Heavy indicator, Start Time of Day, Total Tour Travel Time, Total Tour Emissions, Production Zone and Attraction Zones for each stop, a Travel Time and Service Time for each trip, a Latitude and Longitude for each stop, Emissions for each trip, and the Weight of each truck in Tons.</p>
2,5-Furandicarboxaldehyde as a Bio-based Crosslinking Agent Replacing Glutaraldehyde for Covalent Enzyme Immobilization
<p>In the quest for a bio-based and safer substitute for glutaraldehyde, we have investigated 2,5 diformylfuran (DFF) as bifunctional crosslinking agent for the covalent immobilization of glucoamylase on amino-functionalized methacrylic resins. Immobilization experiments and systematic comparison with glutaraldehyde at four different concentrations for the activation step showed that DFF leads to comparable enzymatic activities at all tested concentrations. Continuous flow experiment confirms a similar long term stability of the immobilized formulations obtained with the two crosslinkers. The NMR study of DFF in aqueous solution evidenced a much simpler behaviour as compared to glutaraldehyde, since no enolic forms can form and only a mono-hydrated form was observed. Unlike in the case of glutaraldehyde, DFF reacts covalently with the primary amino groups <em>via</em> imine bond formation only. Nevertheless, the stability of the covalent immobilization was confirmed also at acidic pH (4.5), most probably because of the higher stability of the imine bonds formed with the aromatic aldehydes. In terms of toxicity DFF has the advantage of being poorly soluble in water and, more importantly, poorly volatile as compared to glutaraldehyde, which displays severe respiratory toxicity. We have performed preliminary ecotoxicity assays using <em>Aliivibrio fischeri</em>, a marine bacterium, evidencing comparable behaviour (below the toxicity threshold) for both dialdehydes at the tested concentrations.</p>
Scientific Value Agent companion data
<p>Companion data for the Scientific Value Agent manuscript. To use, unzip all tarballs into a "results" directory in the root of <a href="https://github.com/matthewcarbone/ScientificValueAgent">https://github.com/matthewcarbone/ScientificValueAgent</a>. All notebooks should then work as-is.</p> <p>Results from 23-09-02 have also been uploaded. These contain some data used in the supplementary data of our manuscript in which we fix the regularization parameter of our procedure.</p>
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advance
ClinicalTrials.gov study NCT03829501. IPD Sharing: YES. Countries: 6. Publications: 0.
A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis
ClinicalTrials.gov study NCT03549871. IPD Sharing: YES. Countries: 15. Publications: 1.
Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )
ClinicalTrials.gov study NCT02633800. IPD Sharing: YES. Countries: 7. Publications: 2.
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or L
ClinicalTrials.gov study NCT03268954. IPD Sharing: YES. Countries: 20. Publications: 1.
Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies
ClinicalTrials.gov study NCT02608268. IPD Sharing: YES. Countries: 9. Publications: 2.
An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML
ClinicalTrials.gov study NCT02610777. IPD Sharing: YES. Countries: 12. Publications: 1.
Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT02812706. IPD Sharing: YES. Countries: 1. Publications: 2.
Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and W
ClinicalTrials.gov study NCT02485691. IPD Sharing: YES. Countries: 13. Publications: 5.
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies
ClinicalTrials.gov study NCT03370302. IPD Sharing: YES. Countries: 3. Publications: 1.
Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
ClinicalTrials.gov study NCT02460224. IPD Sharing: UNDECIDED. Countries: 12. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.